文献速递安宁疗护老年慢病共病管理老年综合评估

晚期疾病患者生命最后一年的医疗费用:回顾性数据库研究

Medical cost of advanced illnesses in the last-year of life-retrospective database study.
PubMed 文献 · Age Ageing · 2022-01-01

该回顾性数据库研究纳入新加坡一家公立医院既往有就诊记录的6598例死亡患者,按晚期癌症、终末期器官衰竭和进行性神经系统疾病分组,量化其生命最后12个月的医疗服务利用与费用。结果显示最后12个月人均医疗费用为20524英镑(95%CI:20013–21036),其中80%来自住院;生命最后2个月费用急剧上升,住院占比从死亡前12个月的61%升至最后1个月的94%。与非癌症晚期疾病患者相比,癌症患者的费用更低,前者最后一年累积费用为后者的1.6倍。

要点

  • 生命最后12个月人均医疗费用为20524英镑,其中80%来自住院。
  • 住院费用占比从死亡前12个月的61%升至最后1个月的94%。
  • 非癌症晚期疾病患者最后一年费用为癌症患者的1.6倍。

核心结论

  • 晚期疾病患者生命最后一年的医疗费用因疾病类型而异,费用在临终前2个月急剧上升,且以住院费用为主。
  • 通过预立医疗照护计划及住院临床团队与社区服务方的紧密协作,或可将部分住院费用转向社区安宁疗护服务。

研究设计与样本

  • 回顾性数据库研究,纳入新加坡一家公立医院既往有住院或门诊就诊记录的死亡患者。
  • 依据诊断编码与临床标准识别晚期疾病患者,采用回溯法量化生命最后12个月的医疗服务利用及相应的月均与年均系统费用。
  • 共纳入6598例死亡患者,按晚期癌症、终末期器官衰竭和进行性神经系统疾病分组比较。

主要发现

  • 6598例死亡患者生命最后12个月的人均医疗费用为20524英镑(95%CI:20013–21036)。
  • 上述费用中80%由住院构成。
  • 费用在生命最后2个月急剧上升,住院占月费用的比例从死亡前12个月的61%升至最后1个月的94%。
  • 与癌症患者相比,非癌症晚期疾病患者在生命最后一年累积的医疗费用为其1.6倍,且终末期器官衰竭与进行性神经系统疾病患者之间存在显著差异。

临床怎么用

  • 关注晚期疾病患者在生命最后一年尤其是最后2个月的住院费用上升,评估住院服务的可替代性。
  • 对非癌症晚期疾病(终末期器官衰竭、进行性神经系统疾病)患者加强费用与照护规划关注。
  • 借助预立医疗照护计划及住院团队与社区服务方的协作,探索将部分住院费用转向社区安宁疗护服务。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aims to quantify medical care utilisation, and to describe the cost trajectories of individuals with advanced illnesses in the last-year of life, differentiated by advanced cancer, end-stage organ failure and progressive neurological disorders. METHODS: This retrospective database study included decedents who had previous inpatient or outpatient encounters at a public hospital in Singapore. Patients with advanced diseases were identified based on diagnostic codes and clinical criteria. Using a look-back approach, the amount of healthcare services utilised and the corresponding mean monthly and annual costs to the healthcare system in the last 12-months of life were quantified. RESULTS: The last 12-months of life among 6,598 decedents was associated with £20,524 (95% confidence interval: £20,013-£21,036) in medical costs, of which 80% was accounted for by inpatient admissions. Costs increased sharply in the last 2-months of life, with a large proportion of monthly costs accounted for by inpatient admissions which rose rapidly from 61% at 12-months prior to death to 94% in the last-month of life. Compared to patients with cancer, individuals diagnosed with non-cancer advanced illnesses accumulated 1.6 times more healthcare costs in the last-year of life with significant differences across patients with end-stage organ failure and progressive neurological disorders. CONCLUSION: Healthcare costs varied across disease conditions at the end-of-life. With advance care planning and close collaboration between the inpatient clinical team and the community providers, it may be possible to re-direct some of the hospitalisation costs to community-based palliative care services.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. Kaur P, Wu HY, Hum A, et al. Medical cost of advanced illnesses in the last-year of life-retrospective database study. Age Ageing. 2022. PMID: 34673931. doi:10.1093/ageing/afab212

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。